首页 | 官方网站   微博 | 高级检索  
     

Bmi-1基因与肿瘤多药耐药性的关系
引用本文:张超,杨春辉综述,孟秀香审校.Bmi-1基因与肿瘤多药耐药性的关系[J].实用肿瘤学杂志,2013,27(4):367-371.
作者姓名:张超  杨春辉综述  孟秀香审校
作者单位:大连医科大学检验医学院(大连 116044)
摘    要:肿瘤干细胞不仅是肿瘤细胞恶性增殖的来源, 也是肿瘤化疗抵抗和复发的根源。肿瘤干细胞对多种化疗药物耐受是基于其干细胞特性。Bmi-1基因是调控干细胞自我更新和增殖活性的关键因素, 和多种恶性肿瘤的发生密切相关。众多研究结果显示, Bmi-1基因可上调ABC转运蛋白的表达量、抑制细胞凋亡, 通过多种途径介导肿瘤的多药耐药性。本文就Bmi-1基因与肿瘤多药耐药性关系研究进展进行综述。

收稿时间:2013-05-20

The relationship between Bmi-1 gene and multidrug resistance
ZHANG Chao,YANG Chunhui,MENG Xiuxiang.The relationship between Bmi-1 gene and multidrug resistance[J].Journal of Practical Oncology,2013,27(4):367-371.
Authors:ZHANG Chao  YANG Chunhui  MENG Xiuxiang
Affiliation:College of Laboratory Medicine, Dalian Medical University, Dalian 116044, China
Abstract:Tumor stem cells are thought to sustain tumor proliferation, chemoresistance and recurrence after therapy.The chemoresistance of tumor stem cells are due to their stem cell properties.Bmi-1 gene plays an important role in self-renewal and proliferation of stem cells, and is associated with a number of malignancies.Bmi-1 gene is reported to display chemoresistance through upregulation of ABC-transporter family, inhibition of cell apoptosis and many other mechanisms.In this review, we make a summary of research advancement on the relationship between Bmi-1 gene and multi drug resistance.
Keywords:
点击此处可从《实用肿瘤学杂志》浏览原始摘要信息
点击此处可从《实用肿瘤学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号